Phathom Pharmaceuticals, Inc. (PHAT)

Phathom Pharmaceuticals, Inc. (PHAT) is a healthcare company (biotechnology) based in the United States. The share price is $5.50, down 6.46% on the day, which values the company at $447.1M. Price as of 18 Nov 2026, 13:00 UTC, from Yahoo Finance.

Key facts

Share price
$5.50−6.46% today
Market value
$447.1M
Forward P/E
6.1×
200-week average
$10.4147% below
Sector
Healthcare

Figures as of . Prices from Yahoo Finance (may be delayed); statements from company filings with the SEC and Yahoo Finance. Estimates, not advice.

Phathom Pharmaceuticals, Inc. in more detail

PHAT trades at 6.1× next year's expected earnings, 1.6× sales. It sits 47% below its 200-week average of $10.41.

Worth checking: Altman Z in the distress zone; Beneish M-score flags the accounts.

Phathom Pharmaceuticals, Inc. (PHAT): questions and answers

What is Phathom Pharmaceuticals, Inc.'s market cap?

Phathom Pharmaceuticals, Inc. is valued at $447.1M at a share price of $5.50.

Is PHAT above its 200-week moving average?

No. PHAT is 47.2% below its 200-week average of $10.41. Long-term investors watch that line because strong companies rarely trade below it for long.

Does PHAT pay a dividend?

Phathom Pharmaceuticals, Inc. does not currently pay a regular dividend.

Cite this page

Funkfolio, “Phathom Pharmaceuticals, Inc. (PHAT) stock: price, valuation and fundamentals”, data as of 18 November 2026. https://funkfolio.com/stock/PHAT

Underlying data: Yahoo Finance; company filings with the SEC.